REQUEST A DEMO
Total
USD $0.00
Search more companies

Mc Biologicheskaya Medicina OOO (Russia)

Main Activities: Hospitals
Full name: Mc Biologicheskaya Medicina OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Mc Biologicheskaya Medicina OOO is an enterprise based in Russia. Its main office is in Surgut. The company operates in the Hospitals industry. The enterprise was incorporated on May 20, 2008. The latest financial highlights indicate a net sales revenue increase of 0.16% in 2023. Over the same period, its total assets grew by 179.17%. The enterprise’s net profit margin decreased by 11.04% in 2023.

Headquarters
Bystrinskaya, 22A, 6
Surgut; Khanty-Mansi Autonomous Okrug - Yugra; Postal Code: 628406

Contact Details: Purchase the Mc Biologicheskaya Medicina OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mc Biologicheskaya Medicina OOO report to view the information.
Registered Capital:
Purchase the Mc Biologicheskaya Medicina OOO report to view the information.
Incorporation Date:
May 20, 2008
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mc Biologicheskaya Medicina OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
0.16%
Total operating revenue
0.16%
Operating profit (EBIT)
-54.61%
Net Profit (Loss) for the Period
-70.5%
Total assets
179.17%
Total equity
192.68%
Operating Profit Margin (ROS)
-10.78%
Net Profit Margin
-11.04%
Return on Equity (ROE)
-65.85%
Debt to Equity Ratio
-10.74%
Quick Ratio
2.17%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?